Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5503840 | Parkinsonism & Related Disorders | 2017 | 7 Pages |
Abstract
Findings imply early alteration of the substantia nigra in XDP mutation carriers prone to develop parkinsonism. Thus, substantia-nigra hyperechogenicity may be regarded as a preclinical risk marker of parkinsonism-predominant XDP. Furthermore, this biomarker is clustered in some families suggesting the existence of one or more genetic co-factors influencing the phenotype of the disease.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Uwe Walter, Raymond Rosales, Alessandro Rocco, Ana Westenberger, Aloysius Domingo, Criscely L. Go, Norbert Brüggemann, Christine Klein, Lillian V. Lee, Dirk Dressler,